Skip to main content
. 2016 Sep 6;7(4):713–724. doi: 10.1007/s13300-016-0196-5

Fig. 2.

Fig. 2

Cross-reacting antibodies at EOT for children participating in the extension trial: a by HbA1c; b by daily basal insulin dose per kg. %B/T percent bound radioactivity relative to the total amount of radioactivity present, EOT end of trial, HbA1c glycated hemoglobin